Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Quote. Real-time Euronext Paris - 01/17 05:15:15 am
91.41 EUR   +0.87%
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/14SANOFI : Déclaration des transactions sur actions propres
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Gets a Neutral rating from Barclays

12/02/2021 | 07:02am EST

Emily Field from Barclays retains his Neutral opinion on the stock. The target price continues to be set at EUR 90.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/14SANOFI : Déclaration des transactions sur actions propres
PU
01/13Sanofi India's Managing Director to Step Down in April
MT
01/13SANOFI : JP Morgan keeps its Buy rating
MD
01/12SANOFI : Exscientia and Sanofi establish strategic research collaboration to develop AI-dr..
PU
01/10Exscientia and Sanofi establish strategic research collaboration to develop AI-driven p..
AQ
01/10Evidation Extends Collaboration with Sanofi to Develop and Apply Real-World Evidence
CI
01/10Alembic Pharmaceuticals Gets US FDA Tentative Nod for Dronedarone Tablets
MT
01/07ADRs End Higher; Exscientia, Shell Among Companies Actively Trading
DJ
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 827 M 43 202 M 43 202 M
Net income 2021 6 167 M 7 043 M 7 043 M
Net Debt 2021 9 857 M 11 258 M 11 258 M
P/E ratio 2021 18,5x
Yield 2021 3,64%
Capitalization 114 B 130 B 130 B
EV / Sales 2021 3,27x
EV / Sales 2022 3,00x
Nbr of Employees 99 412
Free-Float -
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 90,62 €
Average target price 106,75 €
Spread / Average Target 17,8%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI2.30%129 933
JOHNSON & JOHNSON-1.89%441 855
ROCHE HOLDING AG-3.72%323 901
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317